Status:
COMPLETED
Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Nausea
Vomiting
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A multicenter trial to assess the safety and efficacy of an investigational drug in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with confirmed solid tumors who will b...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient is greater than 18 years of age.
- Patient is scheduled to receive his/her first
- course of cisplatin chemotherapy for a solid tumor.
- Patient has a prognosis (life expectancy) greater than or equal to 3 months.
Exclusion
Key Trial Info
Start Date :
January 13 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2004
Estimated Enrollment :
477 Patients enrolled
Trial Details
Trial ID
NCT00090207
Start Date
January 13 2004
End Date
September 30 2004
Last Update
April 24 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.